OBWP
GCVRZ

O'Brien Wealth Partners’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

O'Brien Wealth Partners’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-100
Closed – – 226
2018
Q3 		$0 Buy
+100
New +$54 ﹤0.01% 223
2018
Q2 		– Sell
-100
Closed – – 192
2018
Q1 		$0 Buy
+100
New +$40 ﹤0.01% 188

Other funds holding GCVRZ

SCM
Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return
Elliott Management
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
MCM
Mason Capital Management New York $607M AUM 1.77% 1-Year Est. Return
TPG Group Holdings (SBS) Advisors
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BCM
Brigade Capital Management New York $534M AUM 44.37% 1-Year Est. Return
Highbridge Capital Management
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
Whitebox Advisors
Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
NGA
New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return

O'Brien Wealth Partners's GCVRZ Position: Q4 2018 in Review

O'Brien Wealth Partners sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2018, closing a stake of 100 shares.

O'Brien Wealth Partners first reported a position in GCVRZ in Q1 2018 and held it in 2 quarters. The position peaked at $0 in Q3 2018. 103 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2018.

  • O'Brien Wealth Partners reported no remaining Sanofi Contingent Value Rights position as of Q4 2018 after selling out during the quarter.
  • O'Brien Wealth Partners sold 100 Sanofi Contingent Value Rights shares in Q4 2018.
  • O'Brien Wealth Partners first reported a position in Sanofi Contingent Value Rights in Q1 2018 and held it in 2 quarters.
  • O'Brien Wealth Partners's Sanofi Contingent Value Rights position peaked at $0 in Q3 2018.
  • 103 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2018.

Based on O'Brien Wealth Partners's 13F filing for Q4 2018, filed 17 Jan 2019.